Clinical Trials Browser

Phase 2 × OTHER_GOV × FMT protocol × Clear all

NCT03166397 2023-01-26

Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients

Phase 2 Recruiting

Melanoma